Table 1 Characteristics of patients who received thyroid surgery in this study
Variable | All (%), N = 124 | Bethesda Categories (%) | |||||
|---|---|---|---|---|---|---|---|
I | II | III | IV | V | VI | ||
(non-dx) | (benign) | (AUS/FLUS) | (FN/SFN) | (SFM) | (malignant) | ||
N = 28 | N = 51 | N = 9 | N = 8 | N = 5 | N = 23 | ||
Age | |||||||
 Mean (SD) | 53.6 (14.6) | 54.9 (12.0) | 52.4 (15.8) | 52.6 (15.1) | 65.8 (13.3) | 49.0 (4.6) | 52.1 (15.6) |
  < 55 | 60 (48.4) | 10 (35.7) | 24 (46.1) | 5 (55.5) | 2 (25.0) | 5 (100) | 14 (60.9) |
  > 55 | 64 (51.6) | 18 (64.3) | 27 (53.9) | 4 (44.5) | 6 (75.0) | 0 | 9 (39.1) |
Sex (female) | 107 (86.3) | 27 (96.4) | 47 (90.3) | 8 (88.9) | 4 (50.0) | 3 (60.0) | 18 (78.2) |
Nodule size | |||||||
 1.0–3.9 cm | 95 (76.6) | 28 (100) | 38 (74.5) | 0 | 5 (62.5) | 3 (60.0) | 20 (86.9) |
  ≥ 4.0 cm | 29 (23.4) | 0 | 13 (25.5) | 9 (100) | 3 (37.5) | 2 (40.0) | 3 (13.1) |
Operation | |||||||
 Lobectomy | 84 (73.9) | 22 | 44 | 6 | 8 | 0 | 4 |
 Total +/− Level 6 ND | 35 (25.0) | 6 | 7 | 2 | 0 | 5 | 15 |
 Total + LND | 5 (4.0) | 0 | 0 | 1 | 0 | 0 | 4 |
Surgical pathology | |||||||
 Benign | 84 (67.7) | 24 | 46 | 7 | 7 | 0 | 0 |
 PTC | 31 (25.0) | 3 | 4 | 1 | 1 | 4 | 18 |
 FTC | 3 (2.4) | 1 | 1 | 1 | 0 | 0 | 0 |
 ATC | 6 (4.8) | 0 | 0 | 0 | 0 | 1 | 5 |